SinghA, KaurK, MandalUK, et al.Nanoparticles as budding trends in colon drug delivery for the management of ulcerative colitis. Curr Nanomed, 2020; 10(3):225–247; doi:10.2174/2468187310999200621200615
2.
UngaroR, ColombelJF, LissoosT, et al.A treat-to-target update in ulcerative colitis: A systematic review. Am J Gastroenterol, 2019; 114(6):874; doi:10.1430/9/ajg.0000000000000183
3.
AhmadH, KumarVL. Pharmacotherapy of ulcerative colitis–current status and emerging trends. J Basic Clin Physiol Pharmacol, 2018; 29(6):581–592; doi: 10.1515/jbcpp-2016-0014
4.
PanésJ, AlfaroI. New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol, 2017; 13(10):963–973; doi:10.1080/1744666X.2017.1343668
5.
ChatterjeeP, ChakrabortyC. Emergence of 3D printing technology in the intelligent healthcare systems: A brief drug delivery approach. In: Intell Healthcare. Springer: Singapore, Singapore; 2022; pp. 395–420.
6.
MohapatraS, KarRK, BiswalPK, et al.Approaches of 3D printing in current drug delivery. Sensors Int, 2022; 3:100146; doi.10.1016/j.sintl.2021.100146
7.
Kumar GuptaD, AliMH, AliA, et al.3D printing technology in healthcare: Applications, regulatory understanding, IP repository and clinical trial status. J Drug Target, 2022; 30(2):131–150; doi:10.1080/1061186X.2021.1935973
8.
VargheseR, SoodP, SalviS, et al.3D printing in the pharmaceutical sector: Advances and evidences. Sensors Int, 2022; 25:100177; doi:10.1080/1061186X.2021.1935973
9.
AlmeidaA, LinaresV, Mora-CastañoG, et al.3D printed systems for colon-specific delivery of camptothecin-loaded chitosan micelles. Eur J Pharm Biopharm, 2021; 167:48–56; doi:10.1016/j.ejpb.2021.07.005
10.
Seoane-ViañoI, OngJJ, Luzardo-ÁlvarezA, et al.3D printed tacrolimus suppositories for the treatment of ulcerative colitis. Asian J Pharm, 2021; 16(1):110–119; doi:10.1016/j.ajps.2020.06.003
11.
SunL, OuyangJ, ZengF, et al.An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome. Biomaterials, 283:121468; doi:10.1016/j.biomaterials.2022.121468
12.
Seoane-ViañoI, Gómez-LadoN, Lázare-IglesiasH, et al.3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease. Bio med, 2020; 8(12):563; doi:10.3390/biomedicines8120563
13.
SangnimT, TangpanithanonA, KhamtheantongM, et al.Development of personalized colonic drug delivery systems prepared by 3D-printing technology. Key Eng Mater, 2021; 901:144–150; doi:10.4028/www.scientific.net/KEM.901.144
14.
PistoneM.Personalised medicines by 3D printing: Production of Mini-tablets by direct extrusion of Budesonide medicated powders for the treatment of eosinophilic colitis in paediatric patients. Drug Deliv Transl Res, 2022; 23(17): 213–218; doi: 10.1063/5.0070365
15.
SinghA, MandalUK, NarangRK. Development and characterization of enteric coated pectin pellets containing mesalamine and Saccharomyces boulardii for specific inflamed colon: In vitro and in vivo evaluation. J Drug Deliv Sci Technol, 2021; 62:102393; doi:10.1016/j.jddst.2021.102393
16.
SinghA, MandalUK, NarangRK. Development and in vivo evaluation of pectin based enteric coated microparticles loaded with mesalamine and saccharomyces boulardii for management of ulcerative colitis. Assay Drug Dev Technol, 2022; 20(1):22–34; doi:10.1089/adt.2021.052
